Replies to post #8246 on Intellect Neurosciences Inc. (fka ILNS)

[KaOsiris]

Maybe if I had said 'cash-heavy'? I'm sure there are dozens of poorly capitalized companies who would drool at the thought of magically acquiring the IP of ILNS.

However, is there a well funded, perhaps cash-heavy company in the arena?

And....by 'arena' I mean the small or 'Boutique' bio-med arena.

Why do you think a partner/buyout candidate should or will come from the "small or 'Boutique' bio-med arena" ?

Wouldn't a BP, that is cash-heavy, be more favorable?
Some time ago I pointed to Eli Lilly that try to push their Alzheimer development forward and that are interested especially in the field of tau or combined Amyloid/tau therapeutics where ILNS has a lot of patents and patent application to secure the IP.

And there are of course others that could very well use the IP and developments of ILNS.